Muscular dystrophy research : from molecular diagnosis toward therapy : proceedings of the Satellite Symposium on Muscular Dystrophy Research 90, Venice, Italy, 14-15 September 1990, held in conjunction with the VIIth International Congress on Neuromuscular Diseases, Munich, Germany, 16-22 September 1990
著者
書誌事項
Muscular dystrophy research : from molecular diagnosis toward therapy : proceedings of the Satellite Symposium on Muscular Dystrophy Research 90, Venice, Italy, 14-15 September 1990, held in conjunction with the VIIth International Congress on Neuromuscular Diseases, Munich, Germany, 16-22 September 1990
(International congress series, no. 934)
Excerpta Medica, 1991
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes index
Sole distributors for the USA and Canada, Elsevier Science Pub. Co.
内容説明・目次
内容説明
In the last decade, if not only in the last five years, an unprecedented advance occured in the understanding of the primary defect involved in Duchenne muscular dystrophy. As a consequence, new promising lines and trends of research emerged: molecular diagnosis by use of anti-dystrophin antibodies or by DNA probes and those more strictly dealing with the perspectives of therapy, including myoblast transfer and gene therapy. The many outstanding papers which appear in this volume document the incredible power of modern tools of medical research in unravelling the complexity of the pathology and in finding new therapeutical strategies.
目次
Introductory lecture. A new era for muscular dystrophy research (M. Fardeau). Molecular biology of the Dystrophin gene and its product. Duchenne and Becker muscular dystrophy mutations, studied at the gene and protein level (G.J.B. van Ommen, J.T. den Dunnen, L. Casula, L.A.J. Blonden, P.M. Grootscholten, H.B. Ginjaar, M.H.B. van Paassen, E. Bakker and A.F. Moorman). A comparison of the dystrophin gene structure in primates and lower vertebrates (G. Meng, W. Kress, S. Scherpf, T. Bettecken, W. Feichtinger, W. Schempp, M. Schmid and C.R. Muller). Current knowledge on dystrophin structure and function (E.P. Hoffman). Purification of dystrophin and visualization by rotatory-shadowing in electron microscopy, and deletion detection using domain-specific antibodies (F. Pons, N. Augier, J. Boucraut, R. Heilig, J. Leger, D. Mornet and J.J. Leger). Molecular biology and diagnosis. Molecular biology and diagnosis of muscular dystrophy: Immunocytochemical and immunoblot assays of dystrophin (K. Arahata, T. Ishihara, I. Nonaka and H. Sugita). Mild myopathic syndromes (K.H. Fischbeck). Advances and pitfalls in prenatal diagnosis. Five years DNA-analysis for Duchenne and Becker muscular dystrophy and hemophilia (E. Bakker, A.L.J. Kneppers, E. Voorhoeve, P. Deutz-Terlouw, A.H.J.T. Brocker-Vriends, G.J.B. van Ommen). Direct gene test for Duchenne muscular dystrophy in families without living patients (T. Bettecken and C.R. Muller). Heterozygote diagnosis by dystrophin testing (M. Mora, L. Morandi, M. Gebbia, E. Gussoni and F. Cornelio). Myoblast transfer. Use of normal myogenic cells to repair, replace, and rescue mdx mouse muscle from necrosis (T. Partridge). Myoblast transfer in Duchenne muscular dystrophy. A perspective (G. Karpati). Pioneering development of myoblast transfer therapy (P. Law, T. Goodwin. Q. Fang, M. Chen, Hua-Ju Li, A. Florendo, D. Kirby, T. Bertorini, H. Herrod and G. Golden). Methodologic considerations in clinical studies of myoblast implantation (R.G. Miller, L. Steinman, S. Majumdar, A. Almada, G.K. Pavlath and H.M. Blau). Human myoblast transplantation (J.P. Tremblay, R. Roy, J.-P. Bouchard, J. Huard, C. Labrecque, G. Dansereau, B. Lemieux, M. Goulet and B. Roy). Perspectives of gene therapy. Gene therapy for congenital diseases (S. Rossini and C. Bordignon). Transcripts of the Duchenne muscular dystrophy gene in nonmuscle tissues (D. Yaffe, A. Makover, S. Bar, D. Zuk, E. Barnea and U. Nudel). The dystrophin transcripts in DMD and BMD patients with gene deletion (J. Chelly, H. Gilgenkrantz, M. Lambert, G. Hamard, P. Chafey, D. Recan, I.B. Ginjaar, M. Fardeau, F. Tome, A. Kahn and J.-C. Kaplan). Adenovirus as a vector for gene expression in muscle cells (B. Quantin, L. Stratford-Perricaudet, J.-L. Mandel and M. Perricaudet). Management and therapeutical trials. Therapeutic trials in the management of DMD (V. Dubowitz). A trial with a new steroid in Duchenne muscular dystrophy (C. Angelini, E. Pegoraro, M. Intino, A. Pini, A.
「Nielsen BookData」 より